GlassScriptPhysician profile
Wanda K Panosh
NPI 1992761993
$2,578.77
in general payments reported to CMS, 2019-2025
35 companies · $500 in 2025
The $500 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $486 · 2020: $188 · 2021: $340 · 2022: $101 · 2023: $333 · 2024: $631 · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,463.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $534.00 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $239.20 | 2021-2025 | Mounjaro, Jardiance, Emgality |
| Amgen INC. | $201.87 | 2019-2025 | Evenity, Prolia, Prolia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $195.07 | 2019-2025 | Jardiance |
| Dexcom, INC. | $168.94 | 2021-2024 | Dexcom G6 Transmitter |
| Abbott Laboratories | $144.49 | 2021-2025 | Freestyle Libre 3 |
| Biohaven Pharmaceuticals, INC. | $142.00 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $126.91 | 2023-2025 | Rexulti |
| Amarin Pharma, INC. | $78.10 | 2019-2021 | |
| Pfizer INC. | $65.11 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $64.26 | 2020-2023 | M-M-R II, Gardasil 9, Proquad |
| Dynavax Technologies Corporation | $50.92 | 2024-2025 | Heplisav-B |
| Medtronic, INC. | $46.69 | 2023 | Intellis Adaptivestim |
| Irhythm Technologies, INC. | $43.97 | 2024 | Zio Xt Patch, Zio Monitor |
| Lundbeck LLC | $40.33 | 2024 | Rexulti |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wanda Panosh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.